Abstract --The pathophysiology of Type 2 Diabetes Mellitus (T2DM) is modelled using a coupled system of non-linear deterministic differential equations. An attempt is made to construct to a clinically plausible mathematical model that incorporates the homeostasis associated with endocrinological regulation of glucose and glycogen levels in the human body, by the hormones, insulin and glucagon. The model variables include the concentrations of glucose in the venous blood plasma, the concentration of glycogen in the liver/tissues, the concentration of the hormone glucagon, and the concentration of insulin in the venous blood plasma. The physiological interactions between the model parameters are depicted by clinically measurable rate constants and biophysically quantifiable stoichiometric coefficients. The processes of gluconeogenesis, glycogenolysis, and pulsatile insulin secretion during type 2 diabetes are modelled using plausible auxiliary functions. Investigative computer simulations are performed to elucidate various hypothetical scenarios of glycemia, patho-physiology of T2DM and insulinoma associated hypoglycemia which results from excessive insulin production probably due to a tumor. This study has demonstrated the necessity of simultaneous monitoring of plasma glucose, glucagon, insulin, and glycogen levels in the proper assessment of the pathophysiology of type 2 diabetes and during determination of the therapeutic efficacy of anti-diabetic drugs.
I. INTRODUCTION
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, insulin hypo-secretion to β cell impairment and/or over production of glucose. A person is diagnosed as diabetic if the fasting venous plasma glucose concentration is greater than 126 mg/dL and/or the 2-hour post-glucose load of 75g of anhydrous glucose yield a venous plasma glucose concentration of 200 mg/dL [1] . Alternative novel tests for diagnosis include the use of glycated hemoglobin (Hb A1C ) with suggested levels of about 6.5% [2] .
The pre-disposing historical high risk factors for T2DM include increasing age (old age), central obesity, dietary polyphagia of animal fats, carbonated drinks, lack of physical exercises, familial genetic factors, history of gestational diabetes, polycystic ovary syndrome, and severe mental illness, presence of hypertension, hyperlipidemia, ethnicity and cardio-metabolic factors. Recent emerging risk factors include sleep deprivation, drug-induced metabolic changes, environmental pollutants, low birth weight and fetal malnutrition [3, 4, 5, 6, 7] .
Many mathematical models in the literature were devoted mainly to the dynamics of glucose in relation to the hormone, insulin. The basic model was proposed by Bolie [9] , who used the following system of ordinary differential equations
where G = G(t) represents glucose concentration, I = I(t) represents insulin concentration, and P, a 1 , a 2 , a 3 , a 4 are model parameters.
A clinically relevant minimal model of glucose-insulin dynamics was proposed by Bergman, Bowden, and Cobelli in [10] . De Gaetano Arino [11] constructed a dynamical model of insulin-glucose dynamics using an aggregated integrodifferential delay equations. Several other models were constructed by the following authors: Li et. al. [12] , Cobelli and Tomaseth [13] , Lam et. al. [14] , Mari [8] .
The main objective of the research presented in this paper is to construct a clinically plausible model that depicts the homeostasis of glucose-insulin regulatory dynamics and the pathophysiology of T2DM.
II. DEFINITIONS OF MODEL PARAMETERS
The explicit non-linear deterministic mathematical equations describing the patho-physiology of T2DM are presented in this section. 
III. MODEL EQUATIONS FOR TYPE-2 DIABETES MELLITUS
In this section, an elaborate physiological description and mathematical formulation of the model equations are presented.
A. The Glucose Dynamics Equation
The rate of change of glucose in the body is equal to the post prandial input ( ) (
, plus the rate of glucose production by gluconeogenesis (S 1 (x 3 , x 4 )) which is breakdown of pyruvate into glucose mediated by insulin and glucagon, plus the rate of glucose production by glycogenolysis involving action of glucagon on glycogen ( 
B. The Glycogen Dynamics Equation
Glycogen dynamical equation depends on the postprandial rate of glycogen input ) (
; the bio-synthesis of glycogen term S 2 (x 3 , x 4 ) which is mediated by glucagon and insulin and stored in body tissues including muscle; the rate of de novo synthesis of glycogen due to action of insulin on glucose ( 
C. The Glucagon Dynamics Equation
The rate of change of glucagon in the body equals to the rate of exogenous input (G 3 f 3 (t)) by intravenous or intramuscular injection, plus rate of biosynthesis of glucagon and glycogen (S 3 (x 1 , x 2 )) mediated by the levels of glucose and glycogen, minus the rate of loss of glucagon during glycogenolysis (a 32 x 2 x 3 ) in the liver, minus degradation of glucagon enzymatically (k 3 x 3 ), and minus linear catabolism of glucagon (k 03 ). The glucagon dynamical equation thus takes the following form: 03  3  3  3  2  32  2  1  3  3  3 
D. The Insulin Dynamics Equation
The rate of change of insulin in the venous blood plasma is equal to the rate of exogenous input (G 4 f 4 (t)) by intravenous or sub-cutaneous injection, plus the bio-synthesis of insulin in the β-cells of the islets of Langerhans in the pancreas mediated by the relative concentrations of glucose and glycogen ((S 4 (x 1 , x 2 ) ), minus the rate of insulin catabolism during the mediation of conversion of glucose to glycogen (a 41
x 1 x 4 ), minus the exponential degradation of insulin (k 4 x 4 ), minus the linear degradation of insulin (k 03 ). Thus the insulin dynamical equation takes the form:
IV. COMPUTER SIMULATION RESULTS AND DISCUSSION
In this section, investigative computer simulations are performed to elucidate some aspects of T2DM pathophysiology using hypothetical clinical parametric configurations. For all the simulations, the pulsatile input function f i (t) is defined by the formula:
where n = 24
The time scale for all simulations is hours. The values of rate constants are all estimated and are hypothetical. The units for variables x 1 , x 2 , x 3 , and x 4 are as follow: x 1 (mg/dL), x 2 (g), x 3 (pg/mL), and x 4 (μlU/mL). As shown in Figure 1 , the dynamics of glucose, glycogen, glucagon, and insulin in hypothetical patient #1 seems normal. In particular, the steady status values are approximately 180 mg/dL for x 1 , 160g for x 2 , 40 pg/mL for x 3 , and 10~15 mIU/mL for x 4 . Compared with the standard ranges, the patient's glucose, glycogen, glucagon and insulin levels are regulated by feedback homeostasis. An inspection of the dynamics of glucose, glycogen, glucagon and insulin in hypothetical patient #2 shown in Figure 2 reveals that this patient has hyperglycemia and low insulin levels. Thus the patient is either pre-diabetic or diabetic. In Figure 4 , the hypothetical patient #4 exhibits the clinical manifestations of hypoglycemia which could be probably due to insulinoma that produces excessive levels of insulin that depletes the glucose levels by converting them into glycogen.
B. Hypothetical Patient #2

C. Hypothetical Patient #3
V. CONCLUSION AND DISCUSSION
This research shows the relative importance of mathematical modeling in diabetes research. The major hurdle is how to acquire clinically relevant data to validate the model and perform simulations. The use of Michaelis-Menten type functions make it extremely difficult to estimate the values of the rate constants. In order to solve this problem, hypothetical estimates were used. In the future, more realistic parametric estimates will be used. Nevertheless, this model is one of the first to attempt to describe the pathophysiology of Type 2 Diabetes Mellitus by incorporating most of the physiological aspects of the homeostasis of glucose, glycogen, glucagon and insulin. The computer simulations demonstrate the usefulness of the model equations in describing endocrinopathies associated with insulin and glucagon. 
